Platelet Rich Fibrin for Tear Trough Rejuvenation
Public ClinicalTrials.gov record NCT03313934. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Platelet Rich Fibrin (PRF) With Hyaluronic Acid Fillers for Tear Trough Rejuvenation
Study identification
- NCT ID
- NCT03313934
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Early Phase 1
- Lead sponsor
- Rejuva Medical Aesthetics
- Other
- Enrollment
- 10 participants
Conditions and interventions
Conditions
Interventions
- Hyaluronic Acid Filler and Platelet Rich Fibrin (PRF) Combination Product
- Hyaluronic Acid Filler and Saline Combination Product
Combination Product
Eligibility (public fields only)
- Age range
- 20 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2017
- Primary completion
- Oct 31, 2018
- Completion
- Oct 31, 2018
- Last update posted
- Oct 17, 2017
2017 – 2018
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Rejuva Medical Aesthetics | Los Angeles | California | 90025 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03313934, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 17, 2017 · Synced Jun 26, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03313934 live on ClinicalTrials.gov.